Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-26 9:30 pm Purchase |
2025-03-24 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities III Co-Invest 1 LP | 3,416,032 49.900% |
841,579 (+32.69%) |
Filing History |
| 2024-11-14 10:01 am Purchase |
2024-09-30 | 13G | BIORA THERAPEUTICS INC PAR BIORQ |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 19,958,480 9.990% |
19,958,480 (New Position) |
Filing History |
| 2024-10-09 5:40 pm Purchase |
2024-10-07 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities III Co-Invest 1 LP | 2,574,453 49.900% |
30,716 (+1.21%) |
Filing History |
| 2024-09-13 10:37 am Unchanged |
2024-09-10 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities III Co-Invest 1 LP | 2,543,737 49.900% |
0 (Unchanged) |
Filing History |
| 2024-08-20 4:15 pm Purchase |
2023-12-19 | 13G | Biora Therapeutics, Inc. BIOR |
Davidson Kempner Capital Management LP | 3,731,590 9.900% |
3,731,590 (New Position) |
Filing History |
| 2024-08-14 9:58 pm Purchase |
2024-08-12 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities III Co-Invest 1 LP | 2,543,737 49.900% |
58,291 (+2.35%) |
Filing History |
| 2024-07-08 9:42 pm Purchase |
2024-07-03 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities III Co-Invest 1 LP | 2,485,446 49.900% |
2,485,446 (New Position) |
Filing History |
| 2024-04-02 8:43 pm Purchase |
2024-03-31 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 1,930,628 49.900% |
309,176 (+19.07%) |
Filing History |
| 2024-03-20 6:29 pm Purchase |
2024-03-12 | 13G | Biora Therapeutics, Inc. BIOR |
Context Capital Management LLC | 298,970 9.900% |
298,970 (New Position) |
Filing History |
| 2024-02-14 2:43 pm Purchase |
2023-12-31 | 13G | Biora Therapeutics, Inc. BIOR |
Armistice Capital, LLC | 107,490 3.800% |
107,490 (New Position) |
Filing History |
| 2023-12-20 4:35 pm Purchase |
2023-12-18 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 1,621,453 49.900% |
386,569 (+31.30%) |
Filing History |
| 2023-09-19 4:15 pm Purchase |
2023-09-18 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 1,234,884 49.900% |
867,926 (+236.52%) |
Filing History |
| 2023-03-13 4:18 pm Purchase |
2023-03-10 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 366,958 32.700% |
82,414 (+28.96%) |
Filing History |
| 2023-02-14 12:05 pm Purchase |
2022-12-31 | 13G | Biora Therapeutics, Inc. BIOR |
Armistice Capital, LLC | 1,298,965 5.700% |
1,298,965 (New Position) |
Filing History |
| 2023-01-12 4:46 pm Sale |
2023-01-03 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 284,544 27.800% |
-177,555,628 (-99.84%) |
Filing History |
| 2022-11-18 4:30 pm Purchase |
2022-11-09 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 177,840,173 28.400% |
10,022,310 (+5.97%) |
Filing History |
| 2022-02-14 3:32 pm Sale |
2021-12-31 | 13G | Biora Therapeutics, Inc. BIOR |
CVI Investments, Inc. | 9,375,000 2.200% |
-21,243,073 (-69.38%) |
Filing History |
| 2021-11-26 4:45 pm Purchase |
2021-11-24 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 167,817,863 31.100% |
167,817,863 (New Position) |
Filing History |
| 2021-08-30 10:15 am Purchase |
2021-08-19 | 13G | Biora Therapeutics, Inc. BIOR |
CVI Investments, Inc. | 30,618,073 9.900% |
30,618,073 (New Position) |
Filing History |
| 2021-08-27 4:22 pm Unchanged |
2021-08-24 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Capital Management LP | 184,170,513 47.000% |
0 (Unchanged) |
Filing History |